This study found trends towards improved tolerance which did not reach statistical significance ( p = 0.054). 18 One trial of the discontinued TNX‐901 found a significant difference in threshold dose compared to placebo when participants received 450 mg, but not 150 mg or 300 mg subcutaneous doses. 19 3.3.
← all excerpts
Systematic review of monotherapy with biologicals for children and adults with IgE-mediated food allergy.
1
0.0540
0.0540